Literature DB >> 7354886

H1- and H2-histamine receptor antagonists and induced release of prolactin in male rats.

A O Donoso, A M Banzan.   

Abstract

The effects of 3rd ventricle injection of metiamide, an H2-histamine receptor antagonist and pyrilamine, an H1-histamine receptor antagonist, on the increase of plasma prolactin induced by two doses of histamine in normal male rats were studied. Metiamide did prevent the stimulating action of histamine whereas pyrilamine was not effective. Histamine-induced prolactin release was also blocked by low doses of the 2 antihistamines given in combination. Metiamide per se has no effect but high doses of pyrilamine increased plasma prolactin levels and augmented the hormone response to histamine. The results suggest mediation of H2-receptors in the facilitatory action of histamine on prolactin release.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7354886     DOI: 10.1159/000122967

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  5 in total

1.  Effects of the H2 receptor antagonist ranitidine on anterior pituitary hormone secretion in man.

Authors:  G Delitala; L Devilla; A Pende; A Canessa
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

2.  Prolactin release induced by histamine in maturing male and female rats.

Authors:  E O Alvarez; D Fabra
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

3.  Induction of prolactin release by H1- or H2-histamine agonists in maturing male and female rats.

Authors:  E O Alvarez
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

4.  Release of prolactin and luteinizing hormone by histamine agonists in ovariectomized, steroid-treated rats under ether anesthesia.

Authors:  A O Donoso; M B Zárate
Journal:  Exp Brain Res       Date:  1983       Impact factor: 1.972

5.  Inhibition of histamine receptor H3R suppresses prostate cancer growth, invasion and increases apoptosis via the AR pathway.

Authors:  Jun Chen; Xiao-Yong Hu
Journal:  Oncol Lett       Date:  2018-08-16       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.